ONTOLOGY REPORT - ANNOTATIONS
| Term: | purine ribonucleotide |
|
| Accession: | CHEBI:26400
|
browse the term
|
| Definition: | Any ribonucleotide that has a purine nucleobase. |
| Synonyms: | related_synonym: | purine ribonucleotides |
|
|
3',5'-cyclic AMP
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases abundance |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
multiple interactions |
EXP |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases abundance |
EXP |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases abundance |
EXP |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
multiple interactions |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
increases abundance |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
affects abundance |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
affects abundance |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
increases abundance |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
multiple interactions |
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
increases abundance |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
affects abundance |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
increases chemical synthesis |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
multiple interactions |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
affects abundance |
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:6480464 |
CTD |
| G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
|
multiple interactions |
EXP |
2 |
203,210,376 |
203,244,218 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Alpp |
alkaline phosphatase, placental |
|
multiple interactions |
ISO |
9 |
85,885,336 |
85,888,082 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
multiple interactions |
EXP |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Ank2 |
ankyrin 2, neuronal |
|
multiple interactions |
EXP |
2 |
224,182,431 |
224,501,751 |
RGD:6480464 |
CTD |
| G |
Aqp5 |
aquaporin 5 |
|
multiple interactions |
ISO |
7 |
138,337,725 |
138,341,257 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
EXP |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
multiple interactions |
EXP |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
ISO |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avpr2 |
arginine vasopressin receptor 2 |
|
multiple interactions |
ISO |
X |
159,821,860 |
159,823,488 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
increases activity |
ISO |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
multiple interactions |
EXP |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
increases activity |
EXP |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
C1qtnf5 |
C1q and tumor necrosis factor related protein 5 |
|
multiple interactions |
EXP |
8 |
47,089,564 |
47,091,434 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases abundance |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases abundance |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases abundance |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases abundance |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
20,650,468 |
20,695,147 |
RGD:6480464 |
CTD |
| G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
|
increases phosphorylation |
ISO |
8 |
20,650,468 |
20,695,147 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
multiple interactions |
ISO |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Cd3e |
CD3 molecule, epsilon |
|
decreases phosphorylation |
ISO |
8 |
47,947,257 |
47,958,419 |
RGD:6480464 |
CTD |
| G |
Cd3g |
CD3 molecule, gamma |
|
decreases phosphorylation |
ISO |
8 |
47,924,369 |
47,930,550 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
EXP |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
EXP |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases activity |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases activity |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
EXP |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
increases abundance |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
increases abundance |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
affects secretion |
ISO |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Chsy1 |
chondroitin sulfate synthase 1 |
|
multiple interactions |
EXP |
1 |
120,539,002 |
120,600,102 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
ISO |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
ISO |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
ISO |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
|
multiple interactions |
ISO |
5 |
154,674,754 |
154,702,552 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
EXP |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
multiple interactions |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csk |
c-src tyrosine kinase |
|
multiple interactions |
ISO |
8 |
61,381,336 |
61,386,013 |
RGD:6480464 |
CTD |
| G |
Cstb |
cystatin B (stefin B) |
|
multiple interactions |
EXP |
20 |
10,576,664 |
10,578,706 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
decreases activity |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
multiple interactions |
EXP |
2 |
83,281,937 |
83,335,284 |
RGD:6480464 |
CTD |
| G |
Ddt |
D-dopachrome tautomerase |
|
multiple interactions |
EXP |
20 |
13,591,785 |
13,594,256 |
RGD:6480464 |
CTD |
| G |
Disc1 |
disrupted in schizophrenia 1 |
|
multiple interactions |
ISO |
19 |
55,265,116 |
55,449,375 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
multiple interactions |
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehd2 |
EH-domain containing 2 |
|
multiple interactions |
EXP |
1 |
76,292,179 |
76,310,584 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
multiple interactions |
EXP |
8 |
11,151,051 |
11,180,463 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma, neuronal |
|
multiple interactions |
EXP |
4 |
160,891,003 |
160,897,723 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
multiple interactions |
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:6480464 |
CTD |
| G |
Fam20c |
family with sequence similarity 20, member C |
|
multiple interactions |
EXP |
12 |
16,340,407 |
16,399,325 |
RGD:6480464 |
CTD |
| G |
Fig4 |
FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae) |
|
multiple interactions |
EXP |
20 |
45,123,352 |
45,248,795 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Gabpb1 |
GA binding protein transcription factor, beta subunit 1 |
|
multiple interactions |
EXP |
3 |
114,153,730 |
114,197,849 |
RGD:6480464 |
CTD |
| G |
Gbp2 |
guanylate binding protein 2, interferon-inducible |
|
multiple interactions |
EXP |
2 |
240,523,000 |
240,541,078 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
ISO |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
increases abundance |
EXP |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Glipr2 |
GLI pathogenesis-related 2 |
|
multiple interactions |
EXP |
5 |
60,419,965 |
60,439,957 |
RGD:6480464 |
CTD |
| G |
Glp1r |
glucagon-like peptide 1 receptor |
|
multiple interactions |
ISO |
20 |
9,225,881 |
9,264,184 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
multiple interactions |
ISO |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
multiple interactions |
ISO |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
multiple interactions |
EXP |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
multiple interactions |
EXP |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
multiple interactions |
EXP |
9 |
10,377,808 |
10,385,845 |
RGD:6480464 |
CTD |
| G |
Gypc |
glycophorin C (Gerbich blood group) |
|
multiple interactions |
EXP |
18 |
24,974,608 |
25,006,999 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
decreases abundance |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
decreases abundance |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
multiple interactions |
EXP |
20 |
41,162,093 |
41,186,492 |
RGD:6480464 |
CTD |
| G |
Hist2h2be |
histone cluster 2, H2be |
|
multiple interactions |
EXP |
2 |
191,024,190 |
191,026,614 |
RGD:6480464 |
CTD |
| G |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
|
multiple interactions |
EXP |
1 |
8,783,016 |
9,032,351 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hp |
haptoglobin |
|
multiple interactions |
ISO |
19 |
39,443,016 |
39,447,566 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H 1 |
|
multiple interactions |
ISO |
4 |
150,431,239 |
150,432,699 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
multiple interactions |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh2 |
histamine receptor H 2 |
|
increases abundance |
ISO |
17 |
16,497,967 |
16,499,043 |
RGD:6480464 |
CTD |
| G |
Hrh3 |
histamine receptor H3 |
|
multiple interactions |
EXP |
3 |
169,154,980 |
169,160,064 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
ISO |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1b |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
multiple interactions |
ISO |
8 |
86,700,088 |
86,701,248 |
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
increases abundance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
multiple interactions |
ISO |
1 |
240,136,279 |
240,260,620 |
RGD:6480464 |
CTD |
| G |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
increases abundance |
ISO |
1 |
240,136,279 |
240,260,620 |
RGD:6480464 |
CTD |
| G |
Htra1 |
HtrA serine peptidase 1 |
|
multiple interactions |
EXP |
1 |
190,257,899 |
190,308,325 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
EXP |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
affects response to substance |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
EXP |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il15ra |
interleukin 15 receptor, alpha |
|
multiple interactions |
ISO |
17 |
77,998,621 |
78,029,657 |
RGD:6480464 |
CTD |
| G |
Il15ra |
interleukin 15 receptor, alpha |
|
decreases expression |
ISO |
17 |
77,998,621 |
78,029,657 |
RGD:6480464 |
CTD |
| G |
Il17re |
interleukin 17 receptor E |
|
multiple interactions |
EXP |
4 |
149,348,600 |
149,361,697 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases abundance |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases abundance |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases abundance |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
multiple interactions |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
increases expression |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
multiple interactions |
EXP |
1 |
136,552,358 |
136,642,545 |
RGD:6480464 |
CTD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
multiple interactions |
EXP |
13 |
108,986,973 |
109,006,180 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
multiple interactions |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
multiple interactions |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kif15 |
kinesin family member 15 |
|
multiple interactions |
EXP |
8 |
127,694,272 |
127,764,633 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
increases abundance |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Lamp1 |
lysosomal-associated membrane protein 1 |
|
multiple interactions |
EXP |
16 |
81,213,165 |
81,230,019 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases abundance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases abundance |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
affects secretion |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
multiple interactions |
ISO |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
multiple interactions |
ISO |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases activity |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A/C |
|
multiple interactions |
EXP |
2 |
180,595,724 |
180,616,354 |
RGD:6480464 |
CTD |
| G |
Lurap1l |
leucine rich adaptor protein 1-like |
|
multiple interactions |
EXP |
5 |
99,599,574 |
99,647,041 |
RGD:6480464 |
CTD |
| G |
Man1a1 |
mannosidase, alpha, class 1A, member 1 |
|
multiple interactions |
EXP |
20 |
32,582,507 |
32,766,761 |
RGD:6480464 |
CTD |
| G |
Msantd3 |
Myb/SANT-like DNA-binding domain containing 3 |
|
multiple interactions |
EXP |
5 |
65,226,927 |
65,249,757 |
RGD:6480464 |
CTD |
| G |
Ndufb11 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11 |
|
increases phosphorylation |
ISO |
X |
12,989,912 |
12,992,170 |
RGD:6480464 |
CTD |
| G |
Ndufb11 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11 |
|
multiple interactions |
ISO |
X |
12,989,912 |
12,992,170 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
increases expression |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Npl |
N-acetylneuraminate pyruvate lyase |
|
multiple interactions |
EXP |
13 |
68,524,023 |
68,567,312 |
RGD:6480464 |
CTD |
| G |
Ntan1 |
N-terminal asparagine amidase |
|
multiple interactions |
EXP |
10 |
1,531,025 |
1,545,977 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
multiple interactions |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases activity |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Os9 |
osteosarcoma amplified 9 |
|
multiple interactions |
EXP |
7 |
67,046,802 |
67,073,355 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
EXP |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pde10a |
phosphodiesterase 10A |
|
multiple interactions |
ISO |
1 |
46,392,900 |
46,589,076 |
RGD:6480464 |
CTD |
| G |
Pde10a |
phosphodiesterase 10A |
|
increases hydrolysis |
ISO |
1 |
46,392,900 |
46,589,076 |
RGD:6480464 |
CTD |
| G |
Pde11a |
phosphodiesterase 11A |
|
increases hydrolysis |
ISO |
3 |
58,659,595 |
59,049,869 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
multiple interactions |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
multiple interactions |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
multiple interactions |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde7a |
phosphodiesterase 7A |
|
multiple interactions |
ISO |
2 |
104,339,910 |
104,429,820 |
RGD:6480464 |
CTD |
| G |
Pde7a |
phosphodiesterase 7A |
|
increases hydrolysis |
ISO |
2 |
104,339,910 |
104,429,820 |
RGD:6480464 |
CTD |
| G |
Pde7a |
phosphodiesterase 7A |
|
increases hydrolysis |
ISO |
2 |
104,339,910 |
104,429,820 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
increases hydrolysis |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
increases hydrolysis |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
increases hydrolysis |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
multiple interactions |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde7b |
phosphodiesterase 7B |
|
increases hydrolysis |
ISO |
1 |
15,701,127 |
15,929,632 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
multiple interactions |
ISO |
1 |
137,415,852 |
137,544,337 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
multiple interactions |
ISO |
1 |
137,415,852 |
137,544,337 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
increases hydrolysis |
ISO |
1 |
137,415,852 |
137,544,337 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
increases metabolic processing |
ISO |
1 |
137,415,852 |
137,544,337 |
RGD:6480464 |
CTD |
| G |
Pde8b |
phosphodiesterase 8B |
|
multiple interactions |
ISO |
2 |
25,352,725 |
25,469,209 |
RGD:6480464 |
CTD |
| G |
Pde8b |
phosphodiesterase 8B |
|
multiple interactions |
ISO |
2 |
25,352,725 |
25,469,209 |
RGD:6480464 |
CTD |
| G |
Pde8b |
phosphodiesterase 8B |
|
increases hydrolysis |
ISO |
2 |
25,352,725 |
25,469,209 |
RGD:6480464 |
CTD |
| G |
Pde8b |
phosphodiesterase 8B |
|
increases metabolic processing |
ISO |
2 |
25,352,725 |
25,469,209 |
RGD:6480464 |
CTD |
| G |
Pde9a |
phosphodiesterase 9A |
|
increases hydrolysis |
ISO |
20 |
9,806,117 |
9,901,584 |
RGD:6480464 |
CTD |
| G |
Pfn2 |
profilin 2 |
|
multiple interactions |
EXP |
2 |
147,066,815 |
147,072,519 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
multiple interactions |
EXP |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppp1r14b |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
|
multiple interactions |
EXP |
1 |
209,648,657 |
209,650,767 |
RGD:6480464 |
CTD |
| G |
Prkar2a |
protein kinase, cAMP dependent regulatory, type II alpha |
|
multiple interactions |
EXP |
8 |
113,746,384 |
113,805,476 |
RGD:6480464 |
CTD |
| G |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
|
multiple interactions |
EXP |
6 |
50,234,979 |
50,325,298 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
multiple interactions |
ISO |
1 |
213,437,202 |
213,438,498 |
RGD:6480464 |
CTD |
| G |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
|
multiple interactions |
ISO |
2 |
255,680,691 |
255,759,202 |
RGD:6480464 |
CTD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
multiple interactions |
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pthlh |
parathyroid hormone-like hormone |
|
increases abundance |
ISO |
4 |
184,887,702 |
184,898,841 |
RGD:6480464 |
CTD |
| G |
Ptma |
prothymosin alpha |
|
increases abundance |
ISO |
9 |
85,291,203 |
85,295,242 |
RGD:6480464 |
CTD |
| G |
Rab3b |
RAB3B, member RAS oncogene family |
|
multiple interactions |
EXP |
5 |
130,185,155 |
130,284,038 |
RGD:6480464 |
CTD |
| G |
Rap1b |
RAP1B, member of RAS oncogene family |
|
multiple interactions |
EXP |
7 |
57,132,750 |
57,139,811 |
RGD:6480464 |
CTD |
| G |
Rap1b |
RAP1B, member of RAS oncogene family |
|
multiple interactions |
ISO |
7 |
57,132,750 |
57,139,811 |
RGD:6480464 |
CTD |
| G |
Rbm12 |
RNA binding motif protein 12 |
|
multiple interactions |
EXP |
3 |
146,504,101 |
146,521,424 |
RGD:6480464 |
CTD |
| G |
RGD1310110 |
similar to 3632451O06Rik protein |
|
multiple interactions |
EXP |
15 |
25,680,073 |
25,781,128 |
RGD:6480464 |
CTD |
| G |
RGD1310587 |
similar to hypothetical protein FLJ14146 |
|
multiple interactions |
EXP |
13 |
100,875,932 |
100,885,668 |
RGD:6480464 |
CTD |
| G |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
|
multiple interactions |
EXP |
13 |
67,468,218 |
67,754,947 |
RGD:6480464 |
CTD |
| G |
Rmdn3 |
regulator of microtubule dynamics 3 |
|
multiple interactions |
EXP |
3 |
105,651,318 |
105,671,841 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
multiple interactions |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
increases abundance |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
multiple interactions |
EXP |
6 |
32,253,352 |
32,275,812 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
affects transport |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
affects expression |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
EXP |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
|
multiple interactions |
EXP |
4 |
6,100,783 |
6,117,982 |
RGD:6480464 |
CTD |
| G |
Smoc2 |
SPARC related modular calcium binding 2 |
|
multiple interactions |
EXP |
1 |
53,165,792 |
53,295,145 |
RGD:6480464 |
CTD |
| G |
Snx33 |
sorting nexin 33 |
|
multiple interactions |
EXP |
8 |
60,663,024 |
60,673,400 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
St6gal2 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Tas2r105 |
taste receptor, type 2, member 105 |
|
multiple interactions |
ISO |
4 |
169,393,528 |
169,394,457 |
RGD:6480464 |
CTD |
| G |
Tax1bp1 |
Tax1 (human T-cell leukemia virus type I) binding protein 1 |
|
multiple interactions |
EXP |
4 |
81,021,495 |
81,081,478 |
RGD:6480464 |
CTD |
| G |
Tex14 |
testis expressed 14 |
|
multiple interactions |
EXP |
10 |
75,742,417 |
75,844,797 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tmsbl1 |
thymosin beta-like protein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tmtc4 |
transmembrane and tetratricopeptide repeat containing 4 |
|
multiple interactions |
EXP |
15 |
108,061,644 |
108,118,409 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf12 |
tumor necrosis factor ligand superfamily member 12 |
|
decreases expression |
ISO |
10 |
56,503,756 |
56,513,053 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
increases expression |
EXP |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Trpv4 |
transient receptor potential cation channel, subfamily V, member 4 |
|
multiple interactions |
EXP |
12 |
43,226,933 |
43,265,889 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
ISO |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
ISO |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
multiple interactions |
ISO |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
increases abundance |
ISO |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
multiple interactions |
ISO |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Ttc6 |
tetratricopeptide repeat domain 6 |
|
multiple interactions |
EXP |
6 |
78,244,160 |
78,314,327 |
RGD:6480464 |
CTD |
| G |
Uba5 |
ubiquitin-like modifier activating enzyme 5 |
|
multiple interactions |
EXP |
8 |
109,109,592 |
109,124,197 |
RGD:6480464 |
CTD |
| G |
Vash1 |
vasohibin 1 |
|
multiple interactions |
EXP |
6 |
110,806,294 |
110,818,161 |
RGD:6480464 |
CTD |
| G |
Vash2 |
vasohibin 2 |
|
multiple interactions |
EXP |
13 |
107,030,990 |
107,050,262 |
RGD:6480464 |
CTD |
| G |
Vat1 |
vesicle amine transport protein 1 homolog (T californica) |
|
multiple interactions |
EXP |
10 |
90,483,845 |
90,491,463 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
multiple interactions |
ISO |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
increases abundance |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
multiple interactions |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
increases abundance |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
increases abundance |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
multiple interactions |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
multiple interactions |
ISO |
6 |
143,347,748 |
143,416,680 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
multiple interactions |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
3',5'-cyclic GMP
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases export |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Bdkrb1 |
bradykinin receptor B1 |
|
multiple interactions |
EXP |
6 |
129,760,129 |
129,762,545 |
RGD:6480464 |
CTD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
multiple interactions |
EXP |
6 |
129,744,781 |
129,748,851 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases abundance |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
EXP |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
increases abundance |
EXP |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Gch1 |
GTP cyclohydrolase 1 |
|
affects abundance |
ISO |
15 |
23,023,996 |
23,139,794 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
affects abundance |
ISO |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Il12rb2 |
interleukin 12 receptor, beta 2 |
|
increases expression |
ISO |
4 |
96,929,755 |
96,995,733 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases abundance |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
decreases phosphorylation |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
decreases phosphorylation |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases abundance |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases abundance |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases abundance |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases abundance |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases abundance |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases abundance |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases abundance |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases abundance |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
increases chemical synthesis |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
multiple interactions |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
increases abundance |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
multiple interactions |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Pde10a |
phosphodiesterase 10A |
|
multiple interactions |
ISO |
1 |
46,392,900 |
46,589,076 |
RGD:6480464 |
CTD |
| G |
Pde10a |
phosphodiesterase 10A |
|
increases hydrolysis |
ISO |
1 |
46,392,900 |
46,589,076 |
RGD:6480464 |
CTD |
| G |
Pde11a |
phosphodiesterase 11A |
|
multiple interactions |
ISO |
3 |
58,659,595 |
59,049,869 |
RGD:6480464 |
CTD |
| G |
Pde11a |
phosphodiesterase 11A |
|
increases hydrolysis |
ISO |
3 |
58,659,595 |
59,049,869 |
RGD:6480464 |
CTD |
| G |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
|
multiple interactions |
EXP |
3 |
62,650,092 |
62,928,487 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
decreases abundance |
ISO |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Pde9a |
phosphodiesterase 9A |
|
increases hydrolysis |
ISO |
20 |
9,806,117 |
9,901,584 |
RGD:6480464 |
CTD |
| G |
Pde9a |
phosphodiesterase 9A |
|
multiple interactions |
ISO |
20 |
9,806,117 |
9,901,584 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
affects abundance |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Ptpn12 |
protein tyrosine phosphatase, non-receptor type 12 |
|
increases activity |
EXP |
4 |
9,517,642 |
9,589,954 |
RGD:6480464 |
CTD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
multiple interactions |
ISO |
7 |
11,086,760 |
11,103,522 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases abundance |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
8-bromo-3',5'-cyclic AMP
|
| G |
Clic3 |
chloride intracellular channel 3 |
|
multiple interactions |
ISO |
3 |
3,622,894 |
3,624,805 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
multiple interactions |
ISO |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
multiple interactions |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
multiple interactions |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
increases expression |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases secretion |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Slc25a36l1 |
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36-like 1 |
|
multiple interactions |
ISO |
19 |
34,878,831 |
34,879,927 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
multiple interactions |
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
multiple interactions |
ISO |
2 |
175,908,880 |
175,974,709 |
RGD:6480464 |
CTD |
8-bromo-3',5'-cyclic GMP
|
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
EXP |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
affects localization |
ISO |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
multiple interactions |
ISO |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Prkg1 |
protein kinase, cGMP-dependent, type 1 |
|
increases expression |
EXP |
1 |
234,420,597 |
235,765,375 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1, beta |
|
multiple interactions |
ISO |
1 |
180,682,622 |
180,748,068 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases phosphorylation |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
multiple interactions |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
acetyl-CoA
|
| G |
App |
amyloid beta (A4) precursor protein |
|
affects localization |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
decreases activity |
EXP |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
multiple interactions |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
multiple interactions |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
affects binding |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
multiple interactions |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
adenosine 5'-[gamma-thio]triphosphate
|
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
increases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
affects response to substance |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
ADP
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases secretion |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
decreases response to substance |
ISO |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
increases expression |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
multiple interactions |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
multiple interactions |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
multiple interactions |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases abundance |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
Fga |
fibrinogen alpha chain |
|
multiple interactions |
ISO |
2 |
174,737,640 |
174,753,598 |
RGD:6480464 |
CTD |
| G |
Fga |
fibrinogen alpha chain |
|
increases secretion |
ISO |
2 |
174,737,640 |
174,753,598 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
decreases secretion |
ISO |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fgb |
fibrinogen beta chain |
|
multiple interactions |
ISO |
2 |
174,768,193 |
174,775,102 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
increases secretion |
ISO |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
multiple interactions |
ISO |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases response to substance |
ISO |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
multiple interactions |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga2b |
integrin, alpha 2B |
|
multiple interactions |
ISO |
10 |
91,557,086 |
91,574,194 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mertk |
c-mer proto-oncogene tyrosine kinase |
|
increases response to substance |
ISO |
3 |
116,308,387 |
116,416,414 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nt5e |
5' nucleotidase, ecto |
|
decreases activity |
ISO |
8 |
93,591,630 |
93,635,481 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
affects response to substance |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
multiple interactions |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
multiple interactions |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
increases response to substance |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
affects response to substance |
EXP |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases secretion |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
multiple interactions |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pf4 |
platelet factor 4 |
|
increases secretion |
ISO |
14 |
18,812,550 |
18,813,259 |
RGD:6480464 |
CTD |
| G |
Ppbp |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
increases secretion |
ISO |
14 |
18,816,434 |
18,817,238 |
RGD:6480464 |
CTD |
| G |
Ppp5c |
protein phosphatase 5, catalytic subunit |
|
multiple interactions |
ISO |
1 |
77,345,194 |
77,369,417 |
RGD:6480464 |
CTD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
increases glutathionylation |
EXP |
3 |
159,070,473 |
159,116,792 |
RGD:6480464 |
CTD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
multiple interactions |
EXP |
3 |
159,070,473 |
159,116,792 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Taldo1 |
transaldolase 1 |
|
increases abundance |
ISO |
1 |
201,582,856 |
201,593,187 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases secretion |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tyro3 |
TYRO3 protein tyrosine kinase |
|
increases response to substance |
ISO |
3 |
106,309,671 |
106,328,607 |
RGD:6480464 |
CTD |
ADP-D-ribose
|
| G |
Adprh |
ADP-ribosylarginine hydrolase |
|
increases hydrolysis |
ISO |
11 |
64,079,175 |
64,085,514 |
RGD:6480464 |
CTD |
| G |
Adprhl2 |
ADP-ribosylhydrolase like 2 |
|
increases hydrolysis |
ISO |
5 |
145,685,493 |
145,690,767 |
RGD:6480464 |
CTD |
| G |
Adprhl2 |
ADP-ribosylhydrolase like 2 |
|
multiple interactions |
ISO |
5 |
145,685,493 |
145,690,767 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
EXP |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
multiple interactions |
ISO |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
AMP
|
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
multiple interactions |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
|
multiple interactions |
ISO |
X |
28,682,852 |
28,686,500 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
arachidonoyl-CoA
|
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
ATP
|
| G |
Abca8 |
ATP-binding cassette, subfamily A (ABC1), member 8 |
|
multiple interactions |
ISO |
10 |
99,392,053 |
99,452,833 |
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases hydrolysis |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects binding |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases hydrolysis |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases hydrolysis |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects binding |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases hydrolysis |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
affects binding |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
multiple interactions |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
increases secretion |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
affects binding |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
multiple interactions |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
EXP |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
multiple interactions |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
|
multiple interactions |
EXP |
7 |
138,414,656 |
138,443,272 |
RGD:6480464 |
CTD |
| G |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
|
multiple interactions |
EXP |
10 |
69,103,244 |
70,190,305 |
RGD:6480464 |
CTD |
| G |
Asic3 |
acid-sensing (proton-gated) ion channel 3 |
|
multiple interactions |
EXP |
4 |
6,125,614 |
6,129,660 |
RGD:6480464 |
CTD |
| G |
Atp7a |
ATPase, Cu++ transporting, alpha polypeptide |
|
multiple interactions |
ISO |
X |
94,192,540 |
94,249,776 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
increases phosphorylation |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
multiple interactions |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
increases hydrolysis |
EXP |
18 |
60,748,738 |
60,829,650 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases secretion |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Cabin1 |
calcineurin binding protein 1 |
|
multiple interactions |
EXP |
20 |
13,444,801 |
13,569,453 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
increases activity |
EXP |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
multiple interactions |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing 1 |
|
multiple interactions |
ISO |
8 |
15,732,905 |
15,759,297 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
multiple interactions |
ISO |
5 |
129,007,685 |
129,025,501 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases secretion |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases abundance |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases secretion |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases export |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
affects chemical synthesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
affects chemical synthesis |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases abundance |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
|
increases activity |
ISO |
11 |
35,577,083 |
35,594,291 |
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
multiple interactions |
ISO |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases activity |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
affects response to substance |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
affects binding |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mfn2 |
mitofusin 2 |
|
decreases response to substance |
ISO |
5 |
164,951,252 |
164,980,763 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases activity |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases secretion |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mt-atp6 |
mitochondrially encoded ATP synthase 6 |
|
affects abundance |
EXP |
MT |
7,919 |
8,599 |
RGD:6480464 |
CTD |
| G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
|
increases abundance |
ISO |
MT |
8,599 |
9,382 |
RGD:6480464 |
CTD |
| G |
Nadsyn1 |
NAD synthetase 1 |
|
multiple interactions |
ISO |
1 |
204,187,585 |
204,237,424 |
RGD:6480464 |
CTD |
| G |
Ncs1 |
neuronal calcium sensor 1 |
|
increases response to substance |
EXP |
3 |
10,305,202 |
10,354,149 |
RGD:6480464 |
CTD |
| G |
Ncs1 |
neuronal calcium sensor 1 |
|
multiple interactions |
EXP |
3 |
10,305,202 |
10,354,149 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
affects localization |
EXP |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Nfatc3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
affects localization |
EXP |
19 |
35,907,800 |
35,982,095 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
10 |
45,850,224 |
45,874,533 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
10 |
45,850,224 |
45,874,533 |
RGD:6480464 |
CTD |
| G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
|
multiple interactions |
ISO |
1 |
251,297,417 |
251,308,127 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
affects response to substance |
ISO |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
multiple interactions |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
increases secretion |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
P2rx1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
|
multiple interactions |
EXP |
10 |
59,889,933 |
59,904,985 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
increases activity |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
increases activity |
EXP |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
multiple interactions |
EXP |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
affects activity |
EXP |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases activity |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases activity |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
EXP |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases activity |
ISO |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
multiple interactions |
ISO |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
multiple interactions |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
decreases response to substance |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
EXP |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
increases activity |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2rx7 |
purinergic receptor P2X, ligand-gated ion channel, 7 |
|
multiple interactions |
ISO |
12 |
35,074,025 |
35,117,152 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
affects activity |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
EXP |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
multiple interactions |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
P2ry13 |
purinergic receptor P2Y, G-protein coupled, 13 |
|
multiple interactions |
ISO |
2 |
148,600,612 |
148,601,622 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
increases activity |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
affects activity |
ISO |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
EXP |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry4 |
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
multiple interactions |
ISO |
X |
88,589,534 |
88,590,947 |
RGD:6480464 |
CTD |
| G |
P2ry6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
|
multiple interactions |
ISO |
1 |
158,381,127 |
158,406,783 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
decreases activity |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
increases export |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
multiple interactions |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
decreases activity |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases expression |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
multiple interactions |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
affects binding |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
multiple interactions |
ISO |
2 |
118,640,277 |
118,672,440 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
multiple interactions |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases activity |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases secretion |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppp5c |
protein phosphatase 5, catalytic subunit |
|
multiple interactions |
ISO |
1 |
77,345,194 |
77,369,417 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
increases expression |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
multiple interactions |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Ralbp1 |
ralA binding protein 1 |
|
multiple interactions |
ISO |
9 |
104,617,400 |
104,653,856 |
RGD:6480464 |
CTD |
| G |
Ralbp1 |
ralA binding protein 1 |
|
multiple interactions |
ISO |
9 |
104,617,400 |
104,653,856 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
multiple interactions |
ISO |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Sftpa1 |
surfactant protein A1 |
|
multiple interactions |
ISO |
16 |
17,570,887 |
17,574,389 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
increases secretion |
ISO |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
EXP |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
increases secretion |
EXP |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
increases secretion |
EXP |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
increases secretion |
ISO |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
multiple interactions |
EXP |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc25a14 |
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
|
decreases chemical synthesis |
ISO |
X |
135,035,550 |
135,073,837 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases stability |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects chemical synthesis |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sugt1 |
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
|
multiple interactions |
ISO |
15 |
60,840,998 |
60,881,860 |
RGD:6480464 |
CTD |
| G |
Syn2 |
synapsin II |
|
multiple interactions |
ISO |
4 |
151,255,241 |
151,413,220 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases secretion |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Taldo1 |
transaldolase 1 |
|
increases abundance |
ISO |
1 |
201,582,856 |
201,593,187 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases hydrolysis |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
decreases activity |
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
decreases activity |
EXP |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
ISO |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases activity |
EXP |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
1 |
157,925,514 |
157,928,222 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
1 |
157,896,001 |
157,909,608 |
RGD:6480464 |
CTD |
bucladesine
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects localization |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahrr |
aryl-hydrocarbon receptor repressor |
|
multiple interactions |
ISO |
1 |
29,797,025 |
29,894,912 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases stability |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
multiple interactions |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
multiple interactions |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
multiple interactions |
ISO |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
multiple interactions |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
increases expression |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Cldn5 |
claudin 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
multiple interactions |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
multiple interactions |
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Ctbp1 |
C-terminal binding protein 1 |
|
multiple interactions |
ISO |
14 |
83,022,824 |
83,050,335 |
RGD:6480464 |
CTD |
| G |
Ctbp1 |
C-terminal binding protein 1 |
|
affects localization |
ISO |
14 |
83,022,824 |
83,050,335 |
RGD:6480464 |
CTD |
| G |
Ctbp2 |
C-terminal binding protein 2 |
|
affects localization |
ISO |
1 |
192,463,615 |
192,492,935 |
RGD:6480464 |
CTD |
| G |
Ctbp2 |
C-terminal binding protein 2 |
|
multiple interactions |
ISO |
1 |
192,463,615 |
192,492,935 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fcer2 |
Fc fragment of IgE, low affinity II, receptor for (CD23) |
|
decreases expression |
ISO |
12 |
2,444,054 |
2,469,678 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
multiple interactions |
ISO |
7 |
138,458,875 |
138,466,266 |
RGD:6480464 |
CTD |
| G |
Iapp |
islet amyloid polypeptide |
|
increases expression |
EXP |
4 |
179,855,956 |
179,860,871 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
decreases expression |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
decreases secretion |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
increases expression |
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
decreases expression |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
decreases expression |
EXP |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
multiple interactions |
EXP |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
multiple interactions |
EXP |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Insl3 |
insulin-like 3 |
|
multiple interactions |
EXP |
16 |
18,890,131 |
18,891,475 |
RGD:6480464 |
CTD |
| G |
Insl3 |
insulin-like 3 |
|
increases expression |
EXP |
16 |
18,890,131 |
18,891,475 |
RGD:6480464 |
CTD |
| G |
Insl3 |
insulin-like 3 |
|
multiple interactions |
EXP |
16 |
18,890,131 |
18,891,475 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kat2a |
K(lysine) acetyltransferase 2A |
|
multiple interactions |
ISO |
10 |
89,642,002 |
89,649,953 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
increases activity |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
multiple interactions |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
affects localization |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
decreases secretion |
ISO |
10 |
35,786,877 |
35,788,838 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
decreases expression |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
multiple interactions |
ISO |
3 |
18,498,913 |
18,519,738 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
increases expression |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
multiple interactions |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
decreases activity |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
decreases expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pf4 |
platelet factor 4 |
|
increases expression |
ISO |
14 |
18,812,550 |
18,813,259 |
RGD:6480464 |
CTD |
| G |
Pf4 |
platelet factor 4 |
|
multiple interactions |
ISO |
14 |
18,812,550 |
18,813,259 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
multiple interactions |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
increases activity |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
|
increases expression |
ISO |
12 |
2,610,552 |
2,638,753 |
RGD:6480464 |
CTD |
| G |
Pnpla6 |
patatin-like phospholipase domain containing 6 |
|
multiple interactions |
ISO |
12 |
2,610,552 |
2,638,753 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases activity |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases secretion |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases expression |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Selt |
selenoprotein T |
|
multiple interactions |
EXP |
2 |
147,913,245 |
147,929,296 |
RGD:6480464 |
CTD |
| G |
Selt |
selenoprotein T |
|
increases expression |
EXP |
2 |
147,913,245 |
147,929,296 |
RGD:6480464 |
CTD |
| G |
Slc18a3 |
solute carrier family 18 (vesicular acetylcholine), member 3 |
|
increases expression |
EXP |
16 |
7,969,738 |
7,972,599 |
RGD:6480464 |
CTD |
| G |
Slc18a3 |
solute carrier family 18 (vesicular acetylcholine), member 3 |
|
multiple interactions |
EXP |
16 |
7,969,738 |
7,972,599 |
RGD:6480464 |
CTD |
| G |
Slc2a5 |
solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
|
multiple interactions |
ISO |
5 |
167,240,442 |
167,285,761 |
RGD:6480464 |
CTD |
| G |
Smad6 |
SMAD family member 6 |
|
multiple interactions |
ISO |
8 |
68,144,395 |
68,214,652 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
decreases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
multiple interactions |
EXP |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
increases expression |
EXP |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
coenzyme A
|
| G |
Acot8 |
acyl-CoA thioesterase 8 |
|
affects hydrolysis |
ISO |
3 |
155,828,209 |
155,839,862 |
RGD:6480464 |
CTD |
GDP
|
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
multiple interactions |
ISO |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
decreases activity |
ISO |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
affects binding |
EXP |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
multiple interactions |
EXP |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
GDP-beta-S
|
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
decreases activity |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
glutaryl-CoA
|
| G |
Acot4 |
acyl-CoA thioesterase 4 |
|
affects hydrolysis |
ISO |
6 |
108,075,508 |
108,080,792 |
RGD:6480464 |
CTD |
| G |
Acot8 |
acyl-CoA thioesterase 8 |
|
affects hydrolysis |
ISO |
3 |
155,828,209 |
155,839,862 |
RGD:6480464 |
CTD |
GMP
|
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
decreases activity |
ISO |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
GTP
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
EXP |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
decreases activity |
ISO |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H 1 |
|
multiple interactions |
ISO |
4 |
150,431,239 |
150,432,699 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
affects binding |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
P2ry4 |
pyrimidinergic receptor P2Y, G-protein coupled, 4 |
|
multiple interactions |
EXP |
X |
88,589,534 |
88,590,947 |
RGD:6480464 |
CTD |
| G |
Panx1 |
Pannexin 1 |
|
decreases activity |
ISO |
8 |
11,809,752 |
11,849,392 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
affects binding |
EXP |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
multiple interactions |
EXP |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
increases cleavage |
EXP |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rap1b |
RAP1B, member of RAS oncogene family |
|
multiple interactions |
ISO |
7 |
57,132,750 |
57,139,811 |
RGD:6480464 |
CTD |
| G |
Rap1b |
RAP1B, member of RAS oncogene family |
|
multiple interactions |
EXP |
7 |
57,132,750 |
57,139,811 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
affects binding |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
guanosine 5'-[gamma-thio]triphosphate
|
| G |
Adora2a |
adenosine A2a receptor |
|
multiple interactions |
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
affects binding |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
multiple interactions |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gpr55 |
G protein-coupled receptor 55 |
|
multiple interactions |
ISO |
9 |
84,657,975 |
84,658,934 |
RGD:6480464 |
CTD |
| G |
Hrh4 |
histamine receptor H4 |
|
affects binding |
ISO |
18 |
4,275,671 |
4,292,259 |
RGD:6480464 |
CTD |
| G |
Hrh4 |
histamine receptor H4 |
|
multiple interactions |
ISO |
18 |
4,275,671 |
4,292,259 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
multiple interactions |
EXP |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
increases activity |
EXP |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
affects localization |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
affects localization |
EXP |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
multiple interactions |
EXP |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases activity |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
lauroyl-CoA
|
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
malonyl-CoA
|
| G |
Mlycd |
malonyl-CoA decarboxylase |
|
multiple interactions |
ISO |
19 |
49,637,193 |
49,653,016 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
myristoyl-CoA
|
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects binding |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
oleoyl-CoA
|
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
P(1),P(4)-bis(5'-guanosyl) tetraphosphate
|
| G |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
|
increases metabolic processing |
ISO |
X |
28,682,852 |
28,686,500 |
RGD:6480464 |
CTD |
palmitoyl-CoA
|
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases metabolic processing |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
EXP |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
multiple interactions |
ISO |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases expression |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Shbg |
sex hormone binding globulin |
|
decreases expression |
ISO |
10 |
56,432,474 |
56,435,654 |
RGD:6480464 |
CTD |
stearoyl-CoA
|
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
succinyl-CoA
|
| G |
Acot4 |
acyl-CoA thioesterase 4 |
|
affects hydrolysis |
ISO |
6 |
108,075,508 |
108,080,792 |
RGD:6480464 |
CTD |
Term paths to the root
|